In renal cell cancer (RCC), hypoxia-associated factor (HAF)-mediated HIF-2 transactivation requires SUMOylation of HAF by SUMO1 in an oxygen-sensing manner, contributing to the maximal induction of HIF-2 target genes and tumor progression [65]. The gene discussed is SART1; the disease is renal cell adenocarcinoma.